Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis

Journal of Psychiatric Research
Kate E M GodfreySuresh D Muthukumaraswamy

Abstract

Dysfunction of gamma-aminobutyric acid (GABA) and/or glutamate neurotransmitter systems have increasingly been implicated in the aetiology of Major Depressive Disorder (MDD). It has been proposed that alterations in GABA and/or glutamate result in an imbalance of inhibition and excitation. In a review of the current literature, we identified studies using Magnetic Resonance Spectroscopy (MRS) to examine the neurotransmitters GABA, glutamate, and the composite glutamate/glutamine measure Glx in patients diagnosed with MDD and healthy controls. Results showed patients with MDD had significantly lower GABA levels compared to controls (-0.35 [-0.61,-0.10], p = 0.007). No significant difference was found between levels of glutamate. Sub-analyses were performed, including only studies where the Anterior Cingulate Cortex (ACC) was the region of interest. GABA and Glx levels were lower in the ACC of MDD patients (-0.56 [-0.93,-0.18] p = 0.004, and 0.40 [-0.81,0.01] p = 0.05). This review indicates widespread cortical reduction of GABA in MDD, with a trend towards a localised reduction of Glx in the ACC. However, given both GABA and glutamate appear decreased a simple interpretation in terms of an imbalance of overall excitation-inhibit...Continue Reading

References

Aug 15, 1992·Biological Psychiatry·F PettyA J Rush
Jan 1, 1988·Journal of Psychiatric Research·A HonigP K Bridges
Jan 1, 1982·Archiv für Psychiatrie und Nervenkrankheiten·J S KimH H Kornhuber
Apr 1, 1984·Journal of Affective Disorders·F Petty, A D Sherman
Dec 1, 1981·Journal of Affective Disorders·F Petty, M A Schlesser
Aug 1, 1981·The American Journal of Psychiatry·R H Gerner, T A Hare
Nov 1, 1995·Biological Psychiatry·F PettyA J Rush
Jan 1, 1995·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C AltamuraH Y Meltzer
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Apr 27, 2001·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·P B BarkerM D Boska
Apr 4, 2002·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiPerminder Sachdev
Mar 4, 2003·The American Journal of Psychiatry·Gerard SanacoraJohn H Krystal
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Oct 11, 2003·Biological Psychiatry·Akira KugayaRobert B Innis
Dec 20, 2003·Current Drug Targets. CNS and Neurological Disorders·Justin W C Leung, Hong Xue
Apr 13, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Yousha MirzaDavid R Rosenberg
Jul 9, 2004·Archives of General Psychiatry·Gerard SanacoraGraeme F Mason
Sep 10, 2004·The European Journal of Neuroscience·J Martin VerkuylMarian Joëls
Nov 24, 2004·Journal of Magnetic Resonance Imaging : JMRI·Nader BineshM Albert Thomas
Mar 11, 2005·Expert Opinion on Therapeutic Targets·Steven F KendellGerrard Sanacora
Oct 27, 2005·Psychopharmacology·Veska UzunovaDoncho P Uzunov
May 26, 2006·Psychopharmacology·C Neill EppersonGraeme F Mason
Jun 30, 2006·Psychiatry Research·Aysegul Yildiz-Yesiloglu, Donna Pauler Ankerst
Nov 23, 2006·Depression and Anxiety·Allan V Kalueff, David J Nutt
Jun 19, 2007·Biological Psychiatry·Kenji HashimotoMasaomi Iyo
Jun 26, 2007·Biological Psychiatry·Mounira BanasrRonald S Duman
Jun 29, 2007·Human Brain Mapping·Paul B FitzgeraldZafiris J Daskalakis
Jul 13, 2007·The International Journal of Neuropsychopharmacology·Zubin BhagwagarPhilip J Cowen
Oct 19, 2007·PLoS Medicine·Jan P VandenbrouckeUNKNOWN STROBE Initiative
Jan 29, 2008·Current Psychiatry Reports·Diane WardenStephen R Wisniewski
Jul 22, 2008·Biological Psychiatry·Mounira Banasr, Ronald S Duman

❮ Previous
Next ❯

Citations

Feb 16, 2019·Expert Opinion on Therapeutic Targets·Devon WattsFlavio Kapczinski
Sep 14, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Songqiang HuangDan Xu
Mar 29, 2019·Current Opinion in Rheumatology·Torsten LowinGeorg Pongratz
Jul 14, 2020·Frontiers in Cellular Neuroscience·Antonio BrunoGeorgia Mandolesi
Jun 11, 2019·Clinical Pharmacology and Therapeutics·Jeanette HuiZafiris J Daskalakis
Mar 28, 2019·Frontiers in Cellular Neuroscience·Manoela V Fogaça, Ronald S Duman
Oct 24, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniela L UlianaAnthony A Grace
Nov 21, 2020·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Jessica M DudaDiego A Pizzagalli
Jan 20, 2021·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Helena K KimZafiris J Daskalakis
Mar 16, 2021·European Child & Adolescent Psychiatry·Rebecca HommerKathleen Merikangas
Jul 31, 2020·Frontiers in Neuroendocrinology·Inger Sundström-PoromaaEileen Luders
Oct 3, 2020·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Joana LourençoAlberto Bacci
Oct 18, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gordana Nedic ErjavecNela Pivac
Sep 4, 2021·Psychiatry Research. Neuroimaging·Kate E M GodfreyNicholas Hoeh
May 31, 2021·Translational Psychiatry·Erik D FagerholmJessica R Gilbert
Jan 13, 2022·European Archives of Psychiatry and Clinical Neuroscience·Matti GärtnerSimone Grimm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.